Clinical Observation on Xiaoyao Powder Combined with Intervention of Hepatocellular Carcinoma of Liver-depression and Spleen-deficiency Syndrome

Objective:To observe the effect of Xiaoyao Powder combined with intervention on liver cancer of liver-depression and spleen-deficiency syndrome.Method:56 patients with primary liver cancer who were met the inclusion criteria,were randomly divided into treatment group and control group,28 cases in each group.The control group was treated with intervention therapy,using 5-FU,MMC and DDP through the femoral artery infusion chemotherapy,Iodized oil embolization,which was repeated every 4 weeks and 3 times for a course.Treatment group was given Xiaoyao Powder besides the same therapy as the control group,1 dose a day,which lasted for 1 month.Result:Recent efficacy of two groups had no statistically significant difference(P0.05),the total effective in treatment group was not superior to that in control group;however,quality of life(Karnofsky score) improvement in treatment group was higher(P0.05),the conditions of fatigue,nausea,vomiting,abdominal distension and liver pain in the treatment group were better improved than those in the control group(P0.05).Conclusion:Xiaoyao Powder combined with intervention of hepatocellular carcinoma of liver-depression and spleen-deficiency syndrome has obvious clinical effect,which can alleviate common adverse symptoms,reduce side effects and improve patient quality of life.